This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The new online Learning Center with new content can still be found under the “Training” folder on ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...